Chidamide Combined With Linperlisibon for the Treatment of Refractory/Relapsed Follicular Lymphoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Chidamide Combined With Linperlisibon for the Treatment of Refractory/Relapsed Follicular Lymphoma	B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm	Recruiting	Phase 2	2025-02-19		NCT06158386

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Dongguan People's Hospital	32
Fujian Cancer Hospital	114
Fujian Provincial Hospital	45
Huizhou Municipal Central Hospital	21
Jieyang People's Hospital	14
Shanxi Province Cancer Hospital	43
Sun Yat-sen University	606
The First Affiliated Hospital of Xiamen University	107
The First Affiliated Hospital with Nanjing Medical University	319
Zhangzhou Affiliated Hospital of Fujian Medical University	11

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Bing Xu	Xiamen	China	7